<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCR</journal-id><journal-title-group><journal-title>World Journal of Cancer Research</journal-title></journal-title-group><issn pub-type="epub">2164-9049</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/WJCR.2021.112008</article-id><article-id pub-id-type="publisher-id">WJCR-41852</article-id><article-categories><subj-group subj-group-type="heading"><subject>WJCR20210200000_12040802.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  PG-SGA评分与胃癌患者病理分期的相关性研究
  The Correlation Study of PG-SGA and Pathological Stage of Patients with Gastric Cancer
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>昌利</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>吴</surname><given-names>向华</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>江涛</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>黄</surname><given-names>道来</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>陈</surname><given-names>俊强</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>贾</surname><given-names>葵</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>陆</surname><given-names>利生</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>勇胜</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>献满</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>广西医科大学第一附属医院，心血管内科，广西 南宁</addr-line></aff><aff id="aff2"><addr-line>广西医科大学第一附属医院，胃肠腺体外科，广西 南宁</addr-line></aff><aff id="aff3"><addr-line>广西医科大学第一附属医院，营养科，广西 南宁</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>04</month><year>2021</year></pub-date><volume>11</volume><issue>02</issue><fpage>59</fpage><lpage>65</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：研究患者病理分期、血浆白蛋白、年龄、脉管浸润、肿瘤大小、BMI与胃癌患者主观整体评估(PG-SGA)评分的相关性。探讨胃癌患者病理分期对营养不良风险严重程度的影响。方法：采用连续入组法，纳入我院自2019年8月至2020年8月接受外科手术的248例胃癌患者，入院24小时运用PG-SGA对患者进行营养风险状态评估，并测定患者白蛋白(Alb)、身体质量指数(BMI)，并收集患者的病理报告内容。结果：营养不良风险严重程度在患者脉管浸润、病理分期、年龄、白蛋白、肿瘤大小、BMI有统计学意义p &lt; 0.05。在民族、性别上无统计学意义p &gt; 0.05。筛查出来的影响因素，行logistic回归分析研究。1、BMI是胃癌患者营养不良风险严重程度的独立保护因素，BMI越高，营养不良风险程度越低。2、血浆白蛋白是营养不良风险严重程度的独立保护因素，血浆白蛋白越高，营养不良风险程度越低。3、年龄越高出现的营养不良风险严重程度越高。4、病理分期是营养不良风险程度的独立影响因素，病理分期越高出现的营养不良风险严重程度越高。5、脉管浸润、肿瘤大小不是营养不良风险严重程度的独立影响因素p &gt; 0.05。结论：1、血浆白蛋白、BMI是营养不良风险严重程度的独立保护因素。2、年龄是胃癌患者营养不良风险严重程度的独立危险因素。3、胃癌患者的病理分期越高，患者的营养不良风险越严重，病理分期是营养不良风险严重程度的独立危险因素。
    Objective: To study the correlation between patients’ pathological stage, plasma albumin (Alb), (body mass index) BMI, age, tumor size, vascular infiltration and PG-SGA score of gastric cancer patients; To explore the influence of pathological staging on the severity of malnutrition risk. Methods: 248 patients with gastric cancer who underwent surgical operations in our hospital from August 2019 to August 2020 were enrolled using consecutive sampling in this study. After 24 hours of admission, PG-SGA were used to evaluate the nutritional status of the patient, and to measure the Alb, BMI and collect the content of the patient’s pathology report. Results: The severity of malnutrition risk is statistically significant in patients with vascular infiltration, pathological stage, age, albumin, tumor size, and BMI (p &lt; 0.05). There was no statistically significant in terms of ethnicity, gender (p &gt; 0.05). Based on the influencing factors identified by the above single factor screening, multi-factor logistic analysis was performed. 1. BMI is an independent protective factor for the severity of malnutrition risk in patients with gastric cancer, meaning that the higher the BMI, the lower the risk of malnutrition. 2. Plasma albumin is an independent protective factor for the severity of malnutrition risk. The higher the plasma albumin, the lower the risk of malnutrition. 3. The higher the age, the higher the severity of the risk of malnutrition. 4. Pathological staging is an independent factor influencing the degree of malnutrition risk. The higher the pathological stage, the higher the severity of the risk of malnutrition, which means that the pathological stage is an independent risk factor for the severity of the risk of malnutrition. 5. Vascular infiltration, tumor size are not the independent factors influencing the severity of malnutrition risk (p &gt; 0.05). Conclusion: 1. Alb and BMI are independent protective factors for the severity of malnutrition risk. 2. Age is an independent risk factor for the severity of malnutrition risk. 3. The higher the pathological stage of gastric cancer patients, the more serious the risk of malnutrition. 
  
 
</p></abstract><kwd-group><kwd>胃癌，PG-SGA，白蛋白，BMI，病理分期, Gastric Cancer</kwd><kwd> PG-SGA</kwd><kwd> Albumin</kwd><kwd> BMI</kwd><kwd> Pathological Staging</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：研究患者病理分期、血浆白蛋白、年龄、脉管浸润、肿瘤大小、BMI与胃癌患者主观整体评估(PG-SGA)评分的相关性。探讨胃癌患者病理分期对营养不良风险严重程度的影响。方法：采用连续入组法，纳入我院自2019年8月至2020年8月接受外科手术的248例胃癌患者，入院24小时运用PG-SGA对患者进行营养风险状态评估，并测定患者白蛋白(Alb)、身体质量指数(BMI)，并收集患者的病理报告内容。结果：营养不良风险严重程度在患者脉管浸润、病理分期、年龄、白蛋白、肿瘤大小、BMI有统计学意义p &lt; 0.05。在民族、性别上无统计学意义p &gt; 0.05。筛查出来的影响因素，行logistic回归分析研究。1、BMI是胃癌患者营养不良风险严重程度的独立保护因素，BMI越高，营养不良风险程度越低。2、血浆白蛋白是营养不良风险严重程度的独立保护因素，血浆白蛋白越高，营养不良风险程度越低。3、年龄越高出现的营养不良风险严重程度越高。4、病理分期是营养不良风险程度的独立影响因素，病理分期越高出现的营养不良风险严重程度越高。5、脉管浸润、肿瘤大小不是营养不良风险严重程度的独立影响因素p &gt; 0.05。结论：1、血浆白蛋白、BMI是营养不良风险严重程度的独立保护因素。2、年龄是胃癌患者营养不良风险严重程度的独立危险因素。3、胃癌患者的病理分期越高，患者的营养不良风险越严重，病理分期是营养不良风险严重程度的独立危险因素。</p></sec><sec id="s2"><title>关键词</title><p>胃癌，PG-SGA，白蛋白，BMI，病理分期</p></sec><sec id="s3"><title>The Correlation Study of PG-SGA and Pathological Stage of Patients with Gastric Cancer</title><p>Changli Wang<sup>1</sup>, Xianghua Wu<sup>1*</sup>, Jiangtao Zhang<sup>1</sup>, Daolai Huang<sup>1</sup>, Junqiang Chen<sup>1</sup>, Kui Jia<sup>1</sup>, Lisheng Lu<sup>1</sup>, Yongsheng Zhang<sup>2</sup>, Xianman Wang<sup>3</sup></p><p><sup>1</sup>Division of Gastrointestinal Gland Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning Guangxi</p><p><sup>2</sup>Division of Nutrition, The First Affiliated Hospital of Guangxi Medical University, Nanning Guangxi</p><p><sup>3</sup>Division of Vasculocardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning Guangxi</p><p><img src="//html.hanspub.org/file/4-2150212x5_hanspub.png" /></p><p>Received: Mar. 31<sup>st</sup>, 2021; accepted: Apr. 19<sup>th</sup>, 2021; published: Apr. 26<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/4-2150212x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: To study the correlation between patients’ pathological stage, plasma albumin (Alb), (body mass index) BMI, age, tumor size, vascular infiltration and PG-SGA score of gastric cancer patients; To explore the influence of pathological staging on the severity of malnutrition risk. Methods: 248 patients with gastric cancer who underwent surgical operations in our hospital from August 2019 to August 2020 were enrolled using consecutive sampling in this study. After 24 hours of admission, PG-SGA were used to evaluate the nutritional status of the patient, and to measure the Alb, BMI and collect the content of the patient’s pathology report. Results: The severity of malnutrition risk is statistically significant in patients with vascular infiltration, pathological stage, age, albumin, tumor size, and BMI (p &lt; 0.05). There was no statistically significant in terms of ethnicity, gender (p &gt; 0.05). Based on the influencing factors identified by the above single factor screening, multi-factor logistic analysis was performed. 1. BMI is an independent protective factor for the severity of malnutrition risk in patients with gastric cancer, meaning that the higher the BMI, the lower the risk of malnutrition. 2. Plasma albumin is an independent protective factor for the severity of malnutrition risk. The higher the plasma albumin, the lower the risk of malnutrition. 3. The higher the age, the higher the severity of the risk of malnutrition. 4. Pathological staging is an independent factor influencing the degree of malnutrition risk. The higher the pathological stage, the higher the severity of the risk of malnutrition, which means that the pathological stage is an independent risk factor for the severity of the risk of malnutrition. 5. Vascular infiltration, tumor size are not the independent factors influencing the severity of malnutrition risk (p &gt; 0.05). Conclusion: 1. Alb and BMI are independent protective factors for the severity of malnutrition risk. 2. Age is an independent risk factor for the severity of malnutrition risk. 3. The higher the pathological stage of gastric cancer patients, the more serious the risk of malnutrition.</p><p>Keywords:Gastric Cancer, PG-SGA, Albumin, BMI, Pathological Staging</p><disp-formula id="hanspub.41852-formula30"><graphic xlink:href="//html.hanspub.org/file/4-2150212x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/4-2150212x8_hanspub.png" /> <img src="//html.hanspub.org/file/4-2150212x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>胃癌是我国乃至全球的重大公共卫生问题之一，加重了患者及家庭、社会的负担。据国际癌症研究机构提供的全球肿瘤流行病统计数据，2018年会有1810万肿瘤患者新增病例和960万肿瘤患者的死亡病例。在肿瘤患者中，胃癌的发病率列第五位，死亡率列第三位 [<xref ref-type="bibr" rid="hanspub.41852-ref1">1</xref>]。据2019年国家癌症中心的统计报告 [<xref ref-type="bibr" rid="hanspub.41852-ref2">2</xref>] 指出2015年我国胃癌发病率占所有恶性肿瘤中男性位列第二位，女性位列第五位；其死亡率男性位列第三位，女性位列第二位。由于肿瘤疾病本身消耗、机体代谢需求增加、手术对机体损耗、辅助放化疗等诊疗过程等原因导致的消化道反应、营养摄入障碍及疾病对患者造成的心理负担和经济负担等各种原因，营养不良在胃肠道肿瘤患者中非常常见，胃癌在所有肿瘤中对患者营养的影响最为突出 [<xref ref-type="bibr" rid="hanspub.41852-ref3">3</xref>]。大量研究显示，营养不良可能导致严重的并发症、较差的临床结果、较长的住院时间和较差的预后 [<xref ref-type="bibr" rid="hanspub.41852-ref4">4</xref>]。由于营养不良可引发机体的免疫系统功能障碍，并且胃癌患者的营养状况与患者的癌症的肿瘤分期有密切的关系 [<xref ref-type="bibr" rid="hanspub.41852-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.41852-ref6">6</xref>] [<xref ref-type="bibr" rid="hanspub.41852-ref7">7</xref>]。因此需要研究来确定胃癌的营养状况与患者的肿瘤分期等预后关系，为胃癌患者的营养支持治疗及预后提供临床依据，为该领域的未来研究确立理论基础和方向。</p></sec><sec id="s6"><title>2. 资料与方法</title><sec id="s6_1"><title>2.1. 研究对象</title><p>定点选取自2019年8月至2020年8月在广西医科大学第一附属医院胃肠腺体外科接受外科手术治疗的248例胃癌患者。纳入标准：1、患者知情同意本次研究调查，无任何语言、肢体动作交流障碍，且配合本次研究相关问卷调查与查体，KPS评分 ≥ 70分；2、行手术治疗，患者术前及术后病理证实为胃癌恶性肿瘤，且为初发病例；或者证实胃癌转移的患者3、既往未进行胃肠等相关消化道手术4、年龄18~90岁。剔除标准：1、术前已接受手术治疗、放化疗、免疫治疗等；2、术前合并有严重心、脑、肝、肾等器官相关并发症；3、有精神及认知障碍的患者，无法完成问卷填写；4、有呕血、黑便等既往消化道出血史。5、有糖尿病史。6、进行过器官移植手术。</p></sec><sec id="s6_2"><title>2.2. 研究方法</title><p>根据营养相关指南建议 [<xref ref-type="bibr" rid="hanspub.41852-ref8">8</xref>]，对纳入的248例胃癌患者入院24小时内由科室接受严格培训的营养师及护士进行PG-SGA营养评估，然后双人核对。PG-SGA操作方法参照美国营养与饮食学会(Academy of Nutrition and Dietetics)制定的PG-SGA方法操作标准 [<xref ref-type="bibr" rid="hanspub.41852-ref9">9</xref>]。PG-SGA总体评估结果包括定性评估和定量评估。一般分为四组：0~1分为无营养不良，2~3分为轻度营养不良，4~8分为中度营养不良，≥9分为重度营养不良。PG-SGA ≥ 4分患者视为存在营养不良 [<xref ref-type="bibr" rid="hanspub.41852-ref10">10</xref>]。于入院次日早晨空腹状态测定BMI (空腹体重、脱鞋身高)，抽静脉血送我院检验科进行化验患者的血浆白蛋白(albumin, Alb)水平。并收集患者术后的在我院病理科完成的病理报告内容，肿瘤大小，组织分级，脉管浸润，病理分期。</p></sec><sec id="s6_3"><title>2.3. 观察指标</title><p>观察指标为患者BMI、血浆白蛋白、病理分期、肿瘤转移、民族、性别、肿瘤大小。根据我国成人BMI标准：18.5 ≤ BMI &lt; 24 kg/m<sup>2</sup>营养正常；BMI &lt; 18. 5 kg/m<sup>2</sup>，营养不良；24 ≤ BMI &lt; 28 kg/m<sup>2</sup>超重；BMI ≥ 28.0 kg/m<sup>2</sup>，肥胖 [<xref ref-type="bibr" rid="hanspub.41852-ref11">11</xref>]。血浆白蛋白经全自动生化分析仪测定，其正常值为35~50 g/L。病理分期参照2016年国际抗癌联盟(Union for International Cancer Control, UICC)及美国肿瘤联合会(American Joint Committee on Cancer, AJCC)共同颁布的第8版胃癌分期系统进行分期 [<xref ref-type="bibr" rid="hanspub.41852-ref12">12</xref>]。术中探查发现肝胆及腹膜有癌性结节的为肿瘤转移。民族分为汉族、壮族、其他民族三类。性别分为男性、女性两类。对术中完整切除的胃癌标本用尺子量取肿瘤大小，对有转移的Ⅳ期胃癌患者，术中用尺子测量肿瘤大小。</p></sec><sec id="s6_4"><title>2.4. 统计学分析</title><p>采用SPSS 25.0软件进行数据统计分析，计数资料选择中位数和上下四分位数描述，比较选择卡方检验和秩和检验。计量资料经正态性检验服从正态分布，选择采用均数、标准差的形式描述，比较采用单因素方差分析；不服从正态分布的，选择中位数和上下四分位数描述，比较采用k个独立样本的非参数检验。基于以上单因素筛查出来的可疑的影响因素，行多因素logistic回归分析研究。检验水准α = 0.05。</p></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. 患者的一般资料</title><p>纳入的248例胃癌患者，其中男性158例，女性90例，年龄20~81 (56.42 &#177; 11.87)岁，中位年龄为57岁。按民族分类，其中汉族人数110例(44.4%)，壮族人数127例(51.2%)，其它民族人数11例(4.4%)。病理分期0期9例(3.6%) I期33例(13.3%)，II期46例(18.5%)，III期92例(37.1%)，IV期68例(27.4%)。PG-SGA评分2~3分的人数为17例(6.9%)，4~8分人数为117例(47.2%)，PG-SGA评分 ≥ 9分人数为114例(36.0%)。PG-SGA ≥ 4分的人数为231例(93.15%)。白蛋白24.7~46.4 (35.81 &#177; 3.93) g/L。肿瘤大小1.0~12.0 (6.12 &#177; 2.56) cm。BMI 15.1~32.0 (21.8 &#177; 3.13) kg/m<sup>2</sup>，共有34例(13.7%)患者营养不良，152例(61.3%)患者营养正常，55例(22.2%)患者超重，7例(2.8%)患者肥胖。ALB &lt; 35 g/L共93例(37.5%)，ALB 35~50 g/L共155例(62.5%)。</p></sec><sec id="s7_2"><title>3.2. PG-SGA评分与多因素相关性</title><p>营养不良风险严重程度在患者年龄、脉管浸润、病理分期、白蛋白、肿瘤大小、BMI有统计学意义(p &lt; 0.05)。营养风险严重程度在民族、性别上无统计学意义(p &gt; 0.05)。见表1。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Single factor analysis of the severity of malnutrition ris</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="3"  >PG-SGA</th><th align="center" valign="middle" >χ<sup>2</sup>/Z</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >轻度营养不良</td><td align="center" valign="middle" >中度营养不良</td><td align="center" valign="middle" >重度营养不良</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="3"  >年龄</td><td align="center" valign="middle" >≤44</td><td align="center" valign="middle" >4 (1.61%)</td><td align="center" valign="middle" >21 (8.47%)</td><td align="center" valign="middle" >16 (6.45%)</td><td align="center" valign="middle"  rowspan="3"  >6.030</td><td align="center" valign="middle"  rowspan="3"  >0.049</td></tr><tr><td align="center" valign="middle" >45~59</td><td align="center" valign="middle" >8 (3.23%)</td><td align="center" valign="middle" >53 (21.37%)</td><td align="center" valign="middle" >40 (16.13%)</td></tr><tr><td align="center" valign="middle" >≥60</td><td align="center" valign="middle" >5 (2.02%)</td><td align="center" valign="middle" >43 (17.34%)</td><td align="center" valign="middle" >58 (23.39%)</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >民族</td><td align="center" valign="middle" >汉族</td><td align="center" valign="middle" >6 (2.42%)</td><td align="center" valign="middle" >54 (21.77%)</td><td align="center" valign="middle" >50 (20.16%)</td><td align="center" valign="middle"  rowspan="3"  >0.642</td><td align="center" valign="middle"  rowspan="3"  >0.726</td></tr><tr><td align="center" valign="middle" >壮族</td><td align="center" valign="middle" >11 (4.44%)</td><td align="center" valign="middle" >58 (23.39%)</td><td align="center" valign="middle" >58 (23.39%)</td></tr><tr><td align="center" valign="middle" >其他民族</td><td align="center" valign="middle" >0 (0.00%)</td><td align="center" valign="middle" >5 (2.02%)</td><td align="center" valign="middle" >11 (4.44%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >性别</td><td align="center" valign="middle" >男性</td><td align="center" valign="middle" >8 (3.23%)</td><td align="center" valign="middle" >80 (32.26%)</td><td align="center" valign="middle" >70 (28.23%)</td><td align="center" valign="middle"  rowspan="2"  >−0.235</td><td align="center" valign="middle"  rowspan="2"  >0.814</td></tr><tr><td align="center" valign="middle" >女性</td><td align="center" valign="middle" >9 (3.63%)</td><td align="center" valign="middle" >37 (14.92%)</td><td align="center" valign="middle" >44 (17.74%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >脉管浸润</td><td align="center" valign="middle" >有</td><td align="center" valign="middle" >3 (1.62%)</td><td align="center" valign="middle" >33 (17.84%)</td><td align="center" valign="middle" >40 (21.62%)</td><td align="center" valign="middle"  rowspan="2"  >−2.958</td><td align="center" valign="middle"  rowspan="2"  >0.003</td></tr><tr><td align="center" valign="middle" >无</td><td align="center" valign="middle" >9 (4.86%)</td><td align="center" valign="middle" >66 (35.68%)</td><td align="center" valign="middle" >34 (18.38%)</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >病理分期</td><td align="center" valign="middle" >0期</td><td align="center" valign="middle" >4 (1.61%)</td><td align="center" valign="middle" >5 (2.02%)</td><td align="center" valign="middle" >0 (0.00%)</td><td align="center" valign="middle"  rowspan="5"  >40.412</td><td align="center" valign="middle"  rowspan="5"  >&lt;0.01</td></tr><tr><td align="center" valign="middle" >I期</td><td align="center" valign="middle" >3 (1.21%)</td><td align="center" valign="middle" >26 (10.48%)</td><td align="center" valign="middle" >4 (1.61%)</td></tr><tr><td align="center" valign="middle" >II期</td><td align="center" valign="middle" >1 (0.40%)</td><td align="center" valign="middle" >28 (11.29%)</td><td align="center" valign="middle" >17 (6.85%)</td></tr><tr><td align="center" valign="middle" >III期</td><td align="center" valign="middle" >5 (2.02%)</td><td align="center" valign="middle" >41 (16.53%)</td><td align="center" valign="middle" >46 (18.55%)</td></tr><tr><td align="center" valign="middle" >IV期</td><td align="center" valign="middle" >4 (1.61%)</td><td align="center" valign="middle" >17 (6.85%)</td><td align="center" valign="middle" >47 (18.95%)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >白蛋白</td><td align="center" valign="middle" >37.44 &#177; 2.66</td><td align="center" valign="middle" >36.97 &#177; 3.26</td><td align="center" valign="middle" >34.38 &#177; 4.24</td><td align="center" valign="middle" >15.848</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle"  colspan="2"  >肿瘤大小</td><td align="center" valign="middle" >4.94 &#177; 2.46</td><td align="center" valign="middle" >5.27 &#177; 2.42</td><td align="center" valign="middle" >7.17 &#177; 2.32</td><td align="center" valign="middle" >35.691</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle"  colspan="2"  >BMI</td><td align="center" valign="middle" >23.78 &#177; 2.67</td><td align="center" valign="middle" >22.66 &#177; 2.98</td><td align="center" valign="middle" >20.63 &#177; 2.93</td><td align="center" valign="middle" >17.961</td><td align="center" valign="middle" >&lt;0.01</td></tr></tbody></table></table-wrap><p>表1. 营养不良风险严重程度的单因素分析</p></sec><sec id="s7_3"><title>3.3. 多因素分析</title><p>单因素筛选出了可疑影响因素，分别是病理分期、脉管浸润、年龄、肿瘤大小、白蛋白、BMI，这六个因素需要继续进行后续的二元logistic回归多因素研究。1、血浆白蛋白是营养风险严重程度的独立影响因素，p &lt; 0.05，且影响系数为−0.175 &lt; 0，意味着血浆白蛋白越低，营养风险越严重。2、BMI是营养不良风险严重程度的独立影响因素，p &lt; 0.01，且影响系数为−0.334 &lt; 0，意味着BMI越低，营养风险越严重。3、年龄是营养不良风险严重程度的独立影响因素p &lt; 0.05，从回归系数可以清晰看到，年龄越高出现的营养风险严重程度越高4、病理分期是营养不良风险程度的独立影响因素，病理分期0期、I期、II期的患者出现中度或者重度营养不良风险的可能性显著低于IV期的患者p &lt; 0.05；病理分期III期、IV期之间则无显著差异。从回归系数可以清晰看到，病理分期越高出现的营养不良风险严重程度越高。5、肿瘤大小、脉管浸润不是营养不良风险严重程度的独立影响因素p &gt; 0.05。见表2。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Multi-factor analysis of the severity of malnutrition ris</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >回归系数</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  colspan="2"  >OR的上下限</th><th align="center" valign="middle"  rowspan="2"  >显著性</th></tr></thead><tr><td align="center" valign="middle" >下限</td><td align="center" valign="middle" >上限</td></tr><tr><td align="center" valign="middle" >白蛋白</td><td align="center" valign="middle" >−0.175</td><td align="center" valign="middle" >0.839624</td><td align="center" valign="middle" >0.754011</td><td align="center" valign="middle" >0.934957</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >肿瘤大小</td><td align="center" valign="middle" >0.121</td><td align="center" valign="middle" >1.12851</td><td align="center" valign="middle" >0.912908</td><td align="center" valign="middle" >1.395031</td><td align="center" valign="middle" >0.264</td></tr><tr><td align="center" valign="middle" >BMI</td><td align="center" valign="middle" >−0.334</td><td align="center" valign="middle" >0.715779</td><td align="center" valign="middle" >0.626371</td><td align="center" valign="middle" >0.81795</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >[年龄 = 20~44]</td><td align="center" valign="middle" >−1.003</td><td align="center" valign="middle" >0.366799</td><td align="center" valign="middle" >0.129825</td><td align="center" valign="middle" >1.036333</td><td align="center" valign="middle" >0.047</td></tr><tr><td align="center" valign="middle" >[年龄 = 45~59]</td><td align="center" valign="middle" >−1.110</td><td align="center" valign="middle" >0.329577</td><td align="center" valign="middle" >0.149025</td><td align="center" valign="middle" >0.728875</td><td align="center" valign="middle" >0.006</td></tr><tr><td align="center" valign="middle" >[年龄 ≥ 60]</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >[脉管浸润 = 是]</td><td align="center" valign="middle" >0.106</td><td align="center" valign="middle" >1.111754</td><td align="center" valign="middle" >0.497348</td><td align="center" valign="middle" >2.485174</td><td align="center" valign="middle" >0.796</td></tr><tr><td align="center" valign="middle" >[脉管浸润 = 否]</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >[病理分期 = 0期]</td><td align="center" valign="middle" >−6.311</td><td align="center" valign="middle" >0.001816</td><td align="center" valign="middle" >0.00008</td><td align="center" valign="middle" >0.039663</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >[病理分期 = I期]</td><td align="center" valign="middle" >−3.347</td><td align="center" valign="middle" >0.035182</td><td align="center" valign="middle" >0.003107</td><td align="center" valign="middle" >0.398392</td><td align="center" valign="middle" >0.007</td></tr><tr><td align="center" valign="middle" >[病理分期 = II期]</td><td align="center" valign="middle" >−2.215</td><td align="center" valign="middle" >0.109151</td><td align="center" valign="middle" >0.011874</td><td align="center" valign="middle" >1.003401</td><td align="center" valign="middle" >0.014</td></tr><tr><td align="center" valign="middle" >[病理分期 = III期]</td><td align="center" valign="middle" >−1.570</td><td align="center" valign="middle" >0.20809</td><td align="center" valign="middle" >0.027151</td><td align="center" valign="middle" >1.594845</td><td align="center" valign="middle" >0.131</td></tr><tr><td align="center" valign="middle" >[病理分期 = IV期]</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>表2. 营养不良风险严重程度多因素分析</p></sec></sec><sec id="s8"><title>4. 讨论</title><p>我国幅员辽阔，东、中、西部地区在自然环境、社会经济发展水平、城镇化程度、医疗卫生水平等方面存在差异，尤其在农村地区，大部分就诊时已达到中晚期。本组病人(248例)中，就诊时病理分期为III期及IV期的胃癌患者达102例，占64.52%，其中出现转移的胃癌患者达68例，占患者总数的(27.4%)。据报道日本病理分期为III期及IV期的胃癌患者占(26.9%) [<xref ref-type="bibr" rid="hanspub.41852-ref13">13</xref>]，我国在胃癌患者晚期发病率上比日本高，可能与我国胃癌的早诊早治工作开展较晚有关，也与我国居民不良的饮食习惯密不可分。在肿瘤患者的疾病发展过程中，营养不良从始至终影响肿瘤病程，对患者的临床结局产生不良的影响 [<xref ref-type="bibr" rid="hanspub.41852-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.41852-ref15">15</xref>]。恶性肿瘤患者死于营养不良的约占40%，中度或重度营养不良发生在超过50%的恶性肿瘤患者 [<xref ref-type="bibr" rid="hanspub.41852-ref16">16</xref>] [<xref ref-type="bibr" rid="hanspub.41852-ref17">17</xref>]。所以对肿瘤患者进行营养筛查与营养评估，有利于患者在营养方面的个性化治疗。PG-SGA得到了美国营养师协会 [<xref ref-type="bibr" rid="hanspub.41852-ref18">18</xref>] 等单位的极力推荐并被中国临床肿瘤学会肿瘤营养治疗专家委员会 [<xref ref-type="bibr" rid="hanspub.41852-ref19">19</xref>] 认为现阶段应用最普遍的恶性肿瘤营养不良评估工具。</p><p>在肿瘤分期、BMI、白蛋白、年龄上胃癌患者营养不良风险有显著差异。PG-SGA评分与病理分期正相关。本研究显示，年龄是胃癌营养不良风险严重程度的独立危险因素。年龄20~44和45~59出现中度或者重度营养风险的可能性显著低于年龄 ≥ 60的患者(p &lt; 0.05)。据报道肿瘤患者的病理分期对营养不良风险程度有影响，病理分期越高营养不良风险程度越大 [<xref ref-type="bibr" rid="hanspub.41852-ref20">20</xref>] [<xref ref-type="bibr" rid="hanspub.41852-ref21">21</xref>]。本研究显示，0期患者PG-SGA评分4.33 &#177; 2.50，I期患者PG-SGA评分6.27 &#177; 2.50，II期患者PG-SGA评分7.30 &#177; 2.72，III期患者PG-SGA评分8.75 &#177; 3.16，IV期患者PG-SGA评分10.38 &#177; 3.32，胃癌病理分期越高，患者营养不良风险越大。病理分期0期、I期、II期的患者出现中度或者重度营养不良风险的可能性显著低于IV期的患者(p &lt; 0.05)。病理分期III期、IV期之间则无显著差异。从回归系数可以清晰看到，病理分期越高出现的营养不良风险严重程度越高。血清白蛋白(Alb)常被用来评估患者营养状态，也用于预测恶性肿瘤的预后，低白蛋白肿瘤患者的预后较差。据报道，术前白蛋白水平可以预测胃癌患者预后状况 [<xref ref-type="bibr" rid="hanspub.41852-ref22">22</xref>]。血浆白蛋白越低，营养不良风险越严重，因此血浆白蛋白是营养不良风险严重程度的独立保护因素。研究报道 [<xref ref-type="bibr" rid="hanspub.41852-ref23">23</xref>] 胃癌患者BMI越低其营养状态较差，术后5年的死亡率、疾病进展越高。本研究结果显示，BMI是营养不良风险严重程度的独立保护影响因素，BMI越低，营养不良风险越严重。</p><p>以上结果说明，中国胃癌患者营养不良发生率高而营养治疗率较低，胃癌肿瘤患者的营养状况与其年龄、病理分期、BMI、白蛋白等因素有关。肿瘤的及时确诊和治疗对于改善患者机体的营养状况起着重要作用，肿瘤所处分期越晚，机体营养物质消耗越大，代谢应激紊乱状态持续时间越长，越不利于肿瘤的治疗和患者的预后。我们呼吁重视胃癌患者的营养状况及其营养治疗，重点关注老年、低BMI及进展期肿瘤患者等营养不良高风险人群，整体提高肿瘤患者的临床营养治疗率并改善患者的预后。本研究有一定的局限性，病例数相对少，缺陷在于研究的临床因素不够全面。后续该方面的研究还需更深入、多样本、大数据、多中心的回顾性分析、前瞻性研究去验证与完善。</p></sec><sec id="s9"><title>基金项目</title><p>营养风险筛查评估及血清生化指标联用在胃癌患者围手术期营养治疗中的作用(S2017018)。</p></sec><sec id="s10"><title>文章引用</title><p>王昌利,吴向华,张江涛,黄道来,陈俊强,贾 葵,陆利生,张勇胜,王献满. PG-SGA评分与胃癌患者病理分期的相关性研究The Correlation Study of PG-SGA and Pathological Stage of Patients with Gastric Cancer[J]. 世界肿瘤研究, 2021, 11(02): 59-65. https://doi.org/10.12677/WJCR.2021.112008</p></sec><sec id="s11"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.41852-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA—A Cancer Journal for Clinicians, 68, 394-424.  
https://doi.org/10.3322/caac.21492</mixed-citation></ref><ref id="hanspub.41852-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">孙可欣, 郑荣寿, 张思维. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11.</mixed-citation></ref><ref id="hanspub.41852-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Mariette, C., De Botton, M.-L. and Piessen, G. (2012) Surgery in Esophageal and Gastric Cancer Patients: What Is the Role for Nutrition. Annals of Surgical Oncology, 19, 2128-2134. https://doi.org/10.1245/s10434-012-2225-6</mixed-citation></ref><ref id="hanspub.41852-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Harter, J., Orlandi, S. and Gonzalez, M. (2017) Nutritional and Functional Factors as Prognostic of Surgical Cancer Patients. Supportive Care in Cancer, 25, 2525-2530. https://doi.org/10.1007/s00520-017-3661-4</mixed-citation></ref><ref id="hanspub.41852-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">丁丽平, 张趁欣, 张爽. 消化系统恶性肿瘤患者营养状况及其影响因素分析[J]. 预防医学情报杂志, 2020, 36(9): 1228-1231+1237.</mixed-citation></ref><ref id="hanspub.41852-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">张艳华, 李晓玲, 李增宁. 国内恶性肿瘤患者营养不良影响因素Meta分析[J]. 中国临床保健杂志, 2020, 23(5): 649-655.</mixed-citation></ref><ref id="hanspub.41852-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">李晶, 赵化荣. 恶性肿瘤患者营养状况评估的研究进展[J]. 现代肿瘤医学, 2018, 26(1): 145-148.</mixed-citation></ref><ref id="hanspub.41852-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">吴国豪, 谈善军. 肿瘤患者营养支持指南[J]. 中华外科杂志, 2017, 55(11): 801-829.</mixed-citation></ref><ref id="hanspub.41852-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">石英英, 张晓伟, 袁凯涛, 等. PG-SGA操作标准介绍[J]. 中华肿瘤防治杂志, 2013, 20(22): 1779-1782.</mixed-citation></ref><ref id="hanspub.41852-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Mueller, C., Compher, C. and Ellen, D.M. (2011) A.S.P.E.N. Clinical Guidelines: Nutrition Screening, Assessment, and Intervention in Adults. Journal of Parenteral and Enteral Nutrition, 35, 16-24.  
https://doi.org/10.1177/0148607110389335</mixed-citation></ref><ref id="hanspub.41852-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">中国超重/肥胖医学营养治疗专家共识(2016年版) [J]. 中华糖尿病杂志, 2016, 8(9): 525-540.</mixed-citation></ref><ref id="hanspub.41852-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">陕飞, 李子禹, 张连海, 等. 国际抗癌联盟及美国肿瘤联合会胃癌TNM分期系统(第8版)简介及解读[J]. 中国实用外科杂志, 2017, 37(1): 15-17.</mixed-citation></ref><ref id="hanspub.41852-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Katai, H., Ishikawa, T., Akazawa, K., et al. (2017) Five-Year Survival Analysis of Surgically Resected Gastric Cancer Cases in Japan: A Retrospective Analysis of More than 100,000 Patients from the Nationwide Registry of the Japanese Gastric Cancer Association (2001-2007). Gastric Cancer, 21, 144-154. https://doi.org/10.1007/s10120-017-0716-7</mixed-citation></ref><ref id="hanspub.41852-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Bossola, M. (2015) Nutritional Interventions in Head and Neck Cancer Patients Undergoing. Nutrients, 7, 265-276.  
https://doi.org/10.3390/nu7010265</mixed-citation></ref><ref id="hanspub.41852-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Steenhagen, E., et al. (2017) Nutrition in Peri-Operative Esophageal Cancer Management. Expert Review of Gastroenterology &amp; Hepatology, 11, 663-672. https://doi.org/10.1080/17474124.2017.1325320</mixed-citation></ref><ref id="hanspub.41852-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ryan, A.M., Power, D.G., Daly, L., et al. (2016) Cancer-Associated Malnutrition, Cachexia and Sarcopenia: The Skeleton in the Hospital Closet 40 Years Later. Proceedings of the Nutrition Society, 75, 199-211.  
https://doi.org/10.1017/S002966511500419X</mixed-citation></ref><ref id="hanspub.41852-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Segura, A., et al. (2005) An Epidemiological Evaluation of the Prevalence of Malnutrition in Spanish Patients with Locally Advanced or Metastatic Cancer. Clinical Nutrition, 24, 801-814.</mixed-citation></ref><ref id="hanspub.41852-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Laky, B., et al. (2008) Comparison of Different Nutritional Assessments and Body-Composition Measurements in Detecting Malnutrition among Gynecologic Cancer Patients. The American Journal of Clinical Nutrition, 87, 1678-1685.  
https://doi.org/10.1093/ajcn/87.6.1678</mixed-citation></ref><ref id="hanspub.41852-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">恶性肿瘤患者的营养治疗专家共识[J]. 临床肿瘤学杂志, 2012, 17(1): 59-73.</mixed-citation></ref><ref id="hanspub.41852-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">王贺, 林欣, 康军, 等. 重庆某三甲医院不同分期肺癌住院患者营养风险与营养不良发生率横断面研究[J]. 中华临床营养杂志, 2018, 26(3): 162-169.</mixed-citation></ref><ref id="hanspub.41852-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">沈磊, 杨海涛, 杨春建. 合肥市属部分医疗机构消化道恶性肿瘤住院患者营养现状调查分析[J]. 现代肿瘤医学, 2020, 28(6): 980-983.</mixed-citation></ref><ref id="hanspub.41852-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Oñate-Ocaña, L.F., et al. (2007) Serum Albumin as a Significant Prognostic Factor for Patients with Gastric. Annals of Surgical Oncology, 14, 381-389. https://doi.org/10.1245/s10434-006-9093-x</mixed-citation></ref><ref id="hanspub.41852-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">王贤龙. 体质量指数与胃癌患者临床病理特征及预后的关系[J]. 临床医学研究与实践, 2021(3): 107-109.</mixed-citation></ref></ref-list></back></article>